Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_assertion type Assertion NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_head.
- NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_assertion wasGeneratedBy ECO_0000203 NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_provenance.
- NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_assertion wasDerivedFrom befree-2016 NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_provenance.
- NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_assertion SIO_000772 20660382 NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_provenance.
- NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_assertion evidence source_evidence_literature NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_provenance.
- NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_assertion description "[Of the 12 patients with discordant CTC and (18)F-FDG PET/CT results, 8 (66%) had > or = 5 CTCs, with no evidence of progressive disease at the time of the (18)F-FDG PET/CT study, whereas 4 (33%) had < 5 CTCs, with evidence of progressive disease by (18)F-FDG PET/CT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828376.RA0v6X891J0RZ7qnN35TatNryReWdHVDxa-pm_0X1GfqI130_provenance.